Elevation of serum endothelins and cardiotoxicity induced by particulate matter (PM2.5) in rats with acute myocardial infarction

Cardiovascular Toxicology

Volumn 2, Issue 4, 2002, Pages 253-261

  Kang, Y James ^a,b   Li, Yan ^a   Zhou, Zhanxiang ^a   Roberts, Andrew M ^a   Cai, Lu ^a   Myers, Steven R ^a   Wang, Lipeng ^a   Schuschke, Dale A ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Cardiac arrhythmia; Electrocardiogram; Endothelin receptor; Myocardial infarction; Particulate matter

Indexed keywords

ENDOTHELIN;

ACUTE HEART INFARCTION; AIR POLLUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EPIDEMIOLOGICAL DATA; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; LEFT CORONARY ARTERY; MALE; MORTALITY; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; AIR POLLUTANTS; ANIMALS; ARRHYTHMIA; BIOLOGICAL MARKERS; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ENDOTHELINS; HEART RATE; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MALE; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A;

ANIMALIA; VERTEBRATA;

EID: 0042528362     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:4:253     Document Type: Article

References (36)

1. Dockery, D.W. (2001). Epidemiologic evidence of cardiovascular effects of particulate air pollution. Environ. Health Perspect. 109:483-486.
2. Gordon, T. and Reibman, J. (2000). Cardiovascular toxicity of inhaled ambient particulate matter. Toxicol. Sci. 56:2-4.
3. Peters, A., Liu, E., Verrier, R.L., et al. (2000). Air pollution and incidence of cardiac arrhythmia. Epidemiology 11:11-17.
4. Wellenius, G.A., Saldiva, P.H.N., Batalha, J.R.F., et al. (2002). Electrocardiographic changes during exposure to residual oil fly ash (ROFA) particles in a rat model of myocardial infarction. Toxicol. Sci. 66:327-335.
5. Bouthillier, L., Vincent, R., Goegan, P., et al. (1998). Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothelin-1. Am. J. Pathol. 153:1873-1884.
6. Inoue, A., Yanagisawa, M., Kimura, S., et al. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA 86:2863-2867.
7. Xu, D., Emoto, N., Giaid, A., et al. (1994). ECE-1: a membrane bound metalloprotease that catalyses the proteolytic activation of big endothelin-1. Cell 78:473-485.
8. Harai, H., Hori, S., Aramori, I., Ohkuba, H., and Nakanishi, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:732-735.
9. Molenaar, P., O'Reilly, G., Sharkey, A., et al. (1993). Characterization and localization in the human atrioventricular conducting system and myocardium. Circ. Res. 72:526-538.
10. Davenport, A.P. and Maguire, J.J. (1994). Is endothelin-induced vasoconstriction mediated only by ET-A receptors in humans? Trends Pharmacol. Sci. 15:9-11.
11. Givertz, M.M. and Colucci, W.S. (1998). New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 352:34-38.
12. Sam, F. and Colucci, W.S. (1999). Role of endothelin-1 in myocardial failure. Proc. Assoc. Am. Physicians 111:417-422.
13. Ito, H., Hirata, Y., Adachi, S., et al. (1993). Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92:398-403.
14. McMurray, J.J., Ray, S.G., Abdullah, I., Dargie, H.D., and Morton, J.J. (1992). Plasma endothelin in chronic heart failure. Circulation 85:1374-1379.
15. Cody, R.J., Haas, G.J., Binkley, P.F., Capers, Q., and Kelley, R. (1992). Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85:504-509.
16. Wei, C.M., Lerman, A., Rodeheffer, R.J., et al. (1994). Endothelin in human congestive heart failure. Circulation 89:1580-1586.
17. Monge, J.C. (1998). Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? J. Cardiovasc. Pharmacol. 32:S36-S42.
18. Sakai, S., Miyauchi, T., Kobayash, M., Yamaguchi, I., Goto, K., and Sugishita, Y. (1996). Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384:353-355.
19. Spinale, F.G., Walker, J.D., Mukherjee, R., Iannini, J.P., Keever, A.T., and Gallagher, K.P. (1997). Concomitant endothelin receptor subtype - A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation 95:1918-1929.
20. Spieker, L.E., Noll, G., Ruschitzka, F.T., and Lüscher, T.F. (2001). Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future. J. Am. Coll. Cardiol. 37:1493-1505.
21. Piano, M.R., Bondmass, M., and Schwertz, D.W. (1998). The molecular and cellular pathophysiology of heart failure. Heart Lung 27:3-19.
22. Duru, F., Barton, M., Lüscher, T.F., and Candinas, R. (2001). Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc. Res. 49:272-280.
23. Garjani, A., Zeitlin, W.I.J., Wilson, C., and Slee, S.J. (1995). Effects of endothelin-1 and the ETA-receptor antagonist, BQ 123, on ischemic arrhythmias in anesthetized rats. J. Cardiovasc. Pharmacol. 25:634-642.
24. Douglas, S.A., Nichols, A.J., Feuerstein, G.Z., Elliott, J.D., and Ohlstein, E.H. (1998). SB 209670 inhibits the arrhythmogenic actions of endothelin-1 in the anesthetized dog. J. Cardiovasc. Pharmacol. 31 (Suppl. 1): S99-S102.
25. Gardner, S.Y., Lehmann, J.R., and Costa, D.L. (2000). Oil fly ash-induced elevation of plasma fibrinogen levels in rats. Toxicol. Sci. 56:175-180.
26. Ito, H.,Hirata, Y., Adachi, S., et al. (1993). Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92:398-403.
27. Galatius-Jensen, S., Wroblewski, H., Emmeluth, C., Bie, P., Haunsfl, S., and Kastrup, J. (1994). Plasma endothelin-1 in chronic heart failure: a predictor of cardiac death? Circulation 90:1-379 (abstract).
28. Sakai, S., Miyauchi, T., Sakurai, T., et al. (1996). Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 93:1214-1222.
29. Kobayashi, T., Miyauchi, T., Sakai, S., et al. (1999). Espression of endothelin-1, ET-A and ET-B receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am. J. Physiol. 276(45):H1197-H1206.
30. Picard, P., Smith, P.J., Monge, J.C., et al. (1998). Coordinated upregulation of the cardiac endothelin system in a rat model of heart failure. J. Cardiovasc. Pharmacol. 31:S294-S297.
31. Modesti, P.A., Vanni, S., Paniccia, R., et al. (1999). Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes. J. Cardiovasc. Pharmacol. 34:333-339.
32. Dagassan, P.H., Breu, V., Clozel, M., et al. (1996). Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries. J. Cardiovasc. Pharmacol. 27:147-153.
33. Fukuroda, T., Fujikawa, T., Ozaki, S., et al. (1994). Clearance of circulating endothelin-1 by ET-B receptors in rats. Biochem. Biophys. Res. Commun. 199:1461-1465.
34. Brunner, F. and Doherty, A.M. (1996). Role of ET-B receptors in local clearance of endothelin-1 in rat heart: studies with the antagonist PD 155080 and BQ-788. FEBS Lett. 396:238-242.
35. Fujii, T., Hayashi, S., Hogg, J.C., Vincent, R., and Eeden, S.F.V. (2001). Particulate matter induces cytokine expression in human bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 25:265-271.
36. Eeden, S.F.V., Tan, W.C., Suwa, T., et al. (2001). Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM 10). Am. J. Respir. Crit. Care Med. 164:826-830.